Evidence map›Paper›PMID 26873985›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Expression Profiling of Macrophages Reveals Multiple Populations with Distinct Biological Roles in an Immunocompetent Orthotopic Model of Lung Cancer.

Joanna M Poczobutt, Subhajyoti De, Vinod K Yadav, Teresa T Nguyen, Howard Li, Trisha R Sippel, Mary C M Weiser-Evans, Raphael A Nemenoff

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Article
  2. Article
  3. bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Guidelines on antibody use in physiology research.American journal of physiology. Renal physiology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Lipid metabolism and tumor immunotherapy.Frontiers in cell and developmental biology · 2023
    Review
  15. Review
  16. Article
  17. Article
  18. Evaluation of KRASFrontiers in oncology · 2023
    Article
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Joanna M PoczobuttDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045;
Subhajyoti DeDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045;
Vinod K YadavDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045;
Teresa T NguyenDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045;ORCID http://orcid.org/0000-0002-7211-4176
Howard LiDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045; Veterans Affairs Medical Center, Denver, CO 80220; and.ORCID http://orcid.org/0000-0002-1230-2941
Trisha R SippelDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045;
Mary C M Weiser-EvansDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045; Department of Pharmacology, University of Colorado Denver, Aurora, CO 80045.
Raphael A NemenoffDepartment of Medicine, University of Colorado Denver, Aurora, CO 80045; Department of Pharmacology, University of Colorado Denver, Aurora, CO 80045 Raphael.Nemenoff@ucdenver.edu.

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Tissue Bank and Biomarkers CoreP50CA058187 · NCI · UNIVERSITY OF COLORADO DENVER · PI MILLER, YORK E · 1992 to 2018
$43.8M
Translational Pulmonary Vascular Biology ProgramT32HL007171 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Sonia Castro Flores, Tim Lahm · 1985 to 2026
$9.4M
Training in Translational Research of Lung, Head and Neck CancerT32CA174648 · NCI · UNIVERSITY OF COLORADO DENVER · PI KARAM, SANA D · 2013 to 2022
$4.2M
Preroxisome Proliferator-Activated Receptors in lung CancerR01CA108610 · NCI · UNIVERSITY OF COLORADO DENVER · PI NEMENOFF, RAPHAEL A. · 2004 to 2015
$2.9M
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancerR01CA164780 · NCI · UNIVERSITY OF COLORADO DENVER · PI TUDER, RUBIN M. · 2011 to 2014
$2.3M
Role of cPLA2 in Lung Cancer: Microenvironment vs Tumor CellsR01CA103618 · NCI · UNIVERSITY OF COLORADO DENVER · PI NEMENOFF, RAPHAEL A. · 2003 to 2010
$1.9M
Eicosanoids in Lung Cancer: Progression and MetastasisR01CA162226 · NCI · UNIVERSITY OF COLORADO DENVER · PI NEMENOFF, RAPHAEL A. · 2013 to 2017
$1.6M
The Role of PPARgamma in Lung Cancer Progression and MetastasisIK2BX001282 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI LI, HOWARD · 2012 to 2016
–
BLRD VA IK2 BX001282NCI NIH HHS P30 CA046934NCI NIH HHS P50 CA058187NCI NIH HHS R01 CA103618NCI NIH HHS R01 CA108610NCI NIH HHS R01 CA162226NCI NIH HHS R01 CA164780NCI NIH HHS T32 CA174648NCI NIH HHS T32CA17468NHLBI NIH HHS T32 HL007171
6 · The paper itself

Abstract

Macrophages represent an important component of the tumor microenvironment and play a complex role in cancer progression. These cells are characterized by a high degree of plasticity, and they alter their phenotype in response to local environmental cues. Whereas the M1/M2 classification of macrophages has been widely used, the complexity of macrophage phenotypes has not been well studied, particularly in lung cancer. In this study we employed an orthotopic immunocompetent model of lung adenocarcinoma in which murine lung cancer cells are directly implanted into the left lobe of syngeneic mice. Using multimarker flow cytometry, we defined and recovered several distinct populations of monocytes/macrophages from tumors at different stages of progression. We used RNA-seq transcriptional profiling to define distinct features of each population and determine how they change during tumor progression. We defined an alveolar resident macrophage population that does not change in number and expresses multiple genes related to lipid metabolism and lipid signaling. We also defined a population of tumor-associated macrophages that increase dramatically with tumor and selectively expresses a panel of chemokine genes. A third population, which resembles tumor-associated monocytes, expresses a large number of genes involved in matrix remodeling. By correlating transcriptional profiles with clinically prognostic genes, we show that specific monocyte/macrophage populations are enriched in genes that predict outcomes in lung adenocarcinoma, implicating these subpopulations as critical determinants of patient survival. Our data underscore the complexity of monocytes/macrophages in the tumor microenvironment, and they suggest that distinct populations play specific roles in tumor progression.

Indexed as

AdenocarcinomaAdenocarcinoma of LungAnimalsCarcinogenesisCell Line, TumorChemokinesDisease Models, AnimalExtracellular MatrixGene Expression ProfilingImmunocompetenceLipid MetabolismLung NeoplasmsMacrophages, AlveolarMiceMice, Inbred C57BLMonocytesChemokines

Identifiers

PMID26873985
PMCPMC4779748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.